+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Pharmaceuticals Market by Product Type, Species, Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2026-2032- Product Image
Animal Pharmaceuticals Market by Product Type, Species, Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2026-2032- Product Image
Sale

Animal Pharmaceuticals Market by Product Type, Species, Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337791
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Pharmaceuticals Market is projected to reach USD 47.54 Billion in 2026. It is expected to continue growing at a CAGR of 8.50%, reaching USD 77.71 Billion by 2032.

The animal pharmaceuticals market is being shaped by the convergence of livestock productivity, companion animal wellness, zoonotic disease preparedness, and antimicrobial stewardship. Veterinary pharmaceuticals, including parasiticides, anti-infectives, vaccines, anti-inflammatory drugs, dermatology therapies, reproductive products, and pain management medicines, remain essential to animal health, food security, and public health resilience.

Verified signals from organizations such as WOAH, FAO, USDA, FDA, and EMA show sustained demand for science-backed medicines that improve animal welfare while reducing disease-related production losses. Growth is strongest where veterinary access, pet insurance adoption, herd health programs, cold-chain capability, and regulatory modernization support earlier diagnosis, preventive care, and responsible treatment.

Transformative Shifts Reshaping Animal Health

The competitive landscape is shifting from volume-led therapeutics toward precision prevention, compliance-ready manufacturing, and data-enabled veterinary care. Livestock producers are prioritizing vaccines, diagnostics-linked treatment, and biosecurity programs as avian influenza, African swine fever, foot-and-mouth disease, and other transboundary animal diseases continue to affect global supply chains.

In companion animals, longer pet lifespans and humanization of pets are expanding demand for chronic care medicines, oncology support, dermatology drugs, pain therapies, and specialty injectables. At the same time, tighter antimicrobial use rules in the United States, European Union, and other regulated markets are accelerating innovation in alternatives such as vaccines, immunomodulators, microbiome products, improved husbandry protocols, and targeted therapeutics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across veterinary drug discovery, pharmacovigilance, manufacturing quality, and field disease surveillance. AI-enabled modeling can help screen compounds, identify adverse event patterns, detect outbreak signals, and optimize clinical study design, reducing uncertainty across long development cycles.

In commercial operations, machine learning is improving demand planning for seasonal parasiticides, biologics cold-chain management, and inventory allocation across veterinary clinics, pharmacies, and livestock channels. The highest-value applications are those paired with validated datasets, regulatory traceability, cybersecurity controls, veterinarian oversight, and explainable models that support, not replace, clinical judgment.

Key Regional Insights in Animal Pharmaceuticals

Asia-Pacific is a major growth engine due to large livestock populations, expanding protein consumption, aquaculture intensity, and rising veterinary infrastructure in China, India, Japan, South Korea, Australia, and ASEAN markets. WOAH and FAO disease monitoring continue to highlight the importance of vaccination, parasite control, and biosecurity across the region. North America remains one of the most innovation-intensive regions, supported by strong companion animal spending, FDA-regulated product pathways, pet insurance penetration, established distribution networks, and advanced livestock health systems.

Europe is defined by strict EMA oversight, One Health policies, and reduced antimicrobial use targets, which favor vaccines, diagnostics-linked treatment, pharmacovigilance, and high-compliance manufacturing. Latin America, led by Brazil and Mexico, benefits from export-oriented cattle, poultry, and swine production, where disease prevention and residue compliance are central to market access. The Middle East is investing in food security, equine and camel health, and premium pet care, while Africa shows long-term potential through livestock vaccination, parasite control, public-sector disease programs, and wider access to essential veterinary medicines.

Key Group Insights Across Strategic Markets

ASEAN demand is influenced by poultry, aquaculture, and swine production, with biosecurity, vaccine access, and veterinary extension becoming central to animal health planning. The GCC is increasingly focused on food security, camel and equine care, and companion animal services, supported by premium veterinary clinics, regulated import pathways, and demand for quality-assured pharmaceutical supply.

The European Union sets a global benchmark for veterinary medicine regulation, pharmacovigilance, residue monitoring, and antimicrobial stewardship under harmonized rules. BRICS countries combine large livestock bases, expanding pet ownership, local manufacturing priorities, and improving veterinary access. G7 markets drive R&D, premium therapeutics, biologics quality standards, and advanced pharmacovigilance, while NATO members generally emphasize supply-chain resilience, disease surveillance, and preparedness for zoonotic and cross-border animal health threats.

Key Country Insights for Veterinary Pharmaceuticals

The United States leads in companion animal therapeutics, livestock biologics, prescription channel development, and regulatory transparency through FDA CVM and USDA oversight, while Canada emphasizes high-quality veterinary access, animal welfare, and responsible antimicrobial use. Mexico and Brazil are important livestock medicine markets, with Brazil’s cattle, poultry, and swine industries supporting sustained demand for vaccines, parasiticides, reproductive products, and herd health solutions aligned with export requirements.

The United Kingdom, Germany, France, Italy, and Spain reflect Europe’s shift toward stewardship-led prescribing, preventive medicine, and strong pharmacovigilance, while Russia remains tied to domestic livestock production, vaccination programs, and import substitution. China and India are central to Asia’s volume growth due to large livestock populations, expanding companion animal care, and evolving regulatory oversight. Japan and South Korea favor premium companion animal care, advanced therapeutics, and high clinical standards, while Australia combines export livestock biosecurity, parasite control, and strong veterinary governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated portfolios that balance companion animal specialty care with livestock prevention, including vaccines, parasiticides, anti-inflammatory therapies, dermatology products, pain management medicines, and targeted anti-infectives aligned with antimicrobial stewardship. Investment in pharmacovigilance, real-world evidence, quality systems, and lifecycle management can strengthen regulatory confidence and brand durability.

Companies should also expand regional manufacturing resilience, cold-chain reliability, veterinarian education, and digital engagement with clinics, pharmacies, and producers. Strategic partnerships with diagnostics providers, universities, contract manufacturers, public health agencies, and animal health distributors can accelerate access while supporting evidence-based use across developed and emerging markets.

Research Methodology

This executive summary applies a structured secondary research methodology using verified public sources, regulatory databases, scientific literature, trade statistics, veterinary association publications, and animal disease surveillance resources. Key references include authorities such as WOAH, FAO, FDA, USDA, EMA, national veterinary agencies, and peer-reviewed journals.

Insights are triangulated across product categories, species segments, regional regulations, supply-chain indicators, disease surveillance data, antimicrobial stewardship policies, and end-user demand patterns. The analysis emphasizes data-backed market signals, policy direction, technology adoption, and commercially relevant shifts without relying on unverified claims, market sizing, market share, or unsupported projections.

Conclusion: Growth Through Science, Access, and Stewardship

The animal pharmaceuticals market is entering a more evidence-driven phase where growth depends on innovation, stewardship, access, and trust. Demand for veterinary medicines is supported by pet humanization, protein security, disease prevention, and the need to protect animal and human health under the One Health framework.

Winning organizations will be those that combine regulatory excellence, AI-enabled intelligence, resilient supply chains, and clinically meaningful products. As regional needs diverge, scalable portfolios, responsible antimicrobial strategies, and localized market access models will be essential to sustained leadership in animal pharmaceuticals.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Pharmaceuticals Market, by Product Type
7.1. Anesthetics
7.2. Anti-Inflammatory Medications
7.3. Antibiotics
7.3.1. Fluoroquinolones
7.3.2. Macrolides
7.3.3. Penicillins
7.3.4. Sulfonamides
7.3.5. Tetracyclines
7.4. Hormones & Growth Regulators
7.5. Parasiticides
7.5.1. Anthelmintics
7.5.2. Ectoparasiticides
7.6. Vaccines
7.6.1. Inactivated Vaccines
7.6.2. Live Attenuated Vaccines
7.6.3. Subunit Vaccines
8. Animal Pharmaceuticals Market, by Species
8.1. Aquatic Animals
8.2. Birds
8.3. Companion Animals
8.3.1. Cats
8.3.2. Dogs
8.3.3. Horses
8.4. Livestock Animals
8.4.1. Cattle
8.4.2. Poultry
8.4.3. Sheep & Goats
8.4.4. Swine
8.5. Wild Animals
9. Animal Pharmaceuticals Market, by Route of Administration
9.1. Oral
9.1.1. Capsules
9.1.2. Liquid solutions
9.1.3. Powders
9.1.4. Tablets
9.2. Parenteral
9.3. Topical
9.3.1. Creams
9.3.2. Ointments
9.3.3. Sprays
10. Animal Pharmaceuticals Market, by Disease Type
10.1. Infectious Diseases
10.1.1. Bacterial Infections
10.1.2. Fungal Infections
10.1.3. Parasitic Infestations
10.1.4. Viral Infections
10.2. Non-Infectious Diseases
10.2.1. Inflammatory Diseases
10.2.2. Metabolic Disorders
10.2.3. Nutritional Deficiencies
10.2.4. Reproductive Disorders
11. Animal Pharmaceuticals Market, by End User
11.1. Government & Public Health Organizations
11.2. Livestock Farms & Poultry Farms
11.3. Pet Owners
11.4. Research Institutions
11.5. Veterinary Clinics & Hospitals
12. Animal Pharmaceuticals Market, by Distribution Channels
12.1. Offline Pharmacies
12.2. Online Pharmacies
13. Asia-Pacific Animal Pharmaceuticals Market
14. Europe Animal Pharmaceuticals Market
15. North America Animal Pharmaceuticals Market
16. Latin America Animal Pharmaceuticals Market
17. Africa Animal Pharmaceuticals Market
18. Middle East Animal Pharmaceuticals Market
19. NATO Animal Pharmaceuticals Market
20. G7 Animal Pharmaceuticals Market
21. BRICS Animal Pharmaceuticals Market
22. European Union Animal Pharmaceuticals Market
23. ASEAN Animal Pharmaceuticals Market
24. GCC Animal Pharmaceuticals Market
25. China Animal Pharmaceuticals Market
26. United States Animal Pharmaceuticals Market
27. Japan Animal Pharmaceuticals Market
28. India Animal Pharmaceuticals Market
29. Germany Animal Pharmaceuticals Market
30. United Kingdom Animal Pharmaceuticals Market
31. Australia Animal Pharmaceuticals Market
32. France Animal Pharmaceuticals Market
33. South Korea Animal Pharmaceuticals Market
34. Italy Animal Pharmaceuticals Market
35. Canada Animal Pharmaceuticals Market
36. Russia Animal Pharmaceuticals Market
37. Brazil Animal Pharmaceuticals Market
38. Mexico Animal Pharmaceuticals Market
39. Spain Animal Pharmaceuticals Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Aurora Pharmaceutical, Inc.
41.2. Bimeda Inc.
41.3. Biogénesis Bagó S.A.
41.4. Biovac Ltd.
41.5. Boehringer Ingelheim International GmbH
41.6. Ceva Santé Animale
41.7. Chanelle Pharma
41.8. China Animal Husbandry Industry Co., Ltd.
41.9. Dechra Pharmaceuticals PLC
41.10. ECO Animal Health Group PLC
41.11. Elanco Animal Health Incorporated
41.12. Hester Biosciences Limited
41.13. Huvepharma, Inc.
41.14. Indian Immunologicals Ltd.
41.15. Intas Pharmaceuticals Ltd.
41.16. Laboratorio Drag Pharma Chile Invetec S.A.
41.17. Merck & Co., Inc.
41.18. Neogen Corporation
41.19. Nippon Zenyaku Kogyo Co., Ltd.
41.20. Norbrook Group
41.21. Nutramax Laboratories Veterinary Sciences, Inc
41.22. Orion Corporation
41.23. PetIQ, LLC
41.24. Phibro Animal Health Corporation
41.25. Teknofarma S.r.l.
41.26. Veterinary Pharmaceutical Solutions
41.27. Vetoquinol Group
41.28. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
41.29. Virbac S.A.
41.30. Zendal Group
41.31. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL PHARMACEUTICALS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025 VS 2032 (%)
FIGURE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTHELMINTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTHELMINTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTHELMINTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIRDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL WILD ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL WILD ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL WILD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 199. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 200. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 201. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 202. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 204. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 205. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 206. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 207. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 208. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 209. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 243. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 244. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 245. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 246. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 247. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 248. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 249. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 250. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 251. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 252. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 253. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 254. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 255. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 256. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 257. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 275. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 276. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 277. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 278. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 279. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 280. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 281. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 282. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 283. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 284. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 285. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 286. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 287. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 288. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 289. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 291. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 292. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 293. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 294. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 295. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 296. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 297. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 298. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 299. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 300. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 301. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 302. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 303. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 304. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 305. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 306. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 307. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 308. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 309. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 310. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 311. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 312. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 313. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 314. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 315. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 316. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 317. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 318. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 319. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 320. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 321. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 322. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 329. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 330. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 331. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 332. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 333. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 334. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 335. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 336. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 337. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 338. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 339. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 340. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 341. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 342. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 343. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 344. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 345. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 346. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 347. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 348. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 349. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 350. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 351. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 352. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 353. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 354. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
TABLE 355. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 356. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 357. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 358. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 359. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 360. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 361. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 362. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 363. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 364. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABL

Companies Mentioned

The companies featured in this Animal Pharmaceuticals market report include:
  • Aurora Pharmaceutical, Inc.
  • Bimeda Inc.
  • Biogénesis Bagó S.A.
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec S.A.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Norbrook Group
  • Nutramax Laboratories Veterinary Sciences, Inc
  • Orion Corporation
  • PetIQ, LLC
  • Phibro Animal Health Corporation
  • Teknofarma S.r.l.
  • Veterinary Pharmaceutical Solutions
  • Vetoquinol Group
  • Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • Virbac S.A.
  • Zendal Group
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 47.54 Billion
Forecasted Market Value ( USD ) by 2032 $ 77.71 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Veterinary Therapeutics Market by Product Type, Animal Type, Route of Administration, Disease Type, End User, Distribution Channel - Global Forecast 2026-2032 - Product Image

Veterinary Therapeutics Market by Product Type, Animal Type, Route of Administration, Disease Type, End User, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 3, 2026) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 3, 2026)

  • Training
  • 1 Day
  • Global
Veterinary Pharmaceuticals Market by Product Type, Route of Administration, Animal Type, Indications, Distribution Channel, End User - Global Forecast 2026-2032 - Product Image

Veterinary Pharmaceuticals Market by Product Type, Route of Administration, Animal Type, Indications, Distribution Channel, End User - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.